[DFI] Announcement of Shareholders' Meeting Resolution to Lift Non-Compete Restrictions for Directors and Representatives

1. Date of Shareholders' Meeting: 2026/05/27 2. Names and titles of directors permitted to engage in competitive activities: (List includes Qisda Corporation and its representatives Chen Chi-hung, Tseng Wen-hsing, Tien Chih-ying, and independent directors). 3. Items of permitted competitive activities: (Detailed list of concurrent positions in various Qisda-affiliated companies). 4. Duration of permission: During the term of office as a director or representative of the company. 5. Resolution status: Approved by a majority of votes represented by shareholders holding at least two-thirds of the total issued shares. 6. Competitive activities involving Mainland China: Chen Chi-hung and Tseng Wen-hsing. 7. Mainland China entities and positions: Positions in Nanjing BenQ Hospital, Suzhou BenQ Hospital, etc. 8. Addresses of Mainland China entities: Locations in Nanjing and Suzhou. 9. Business scope in Mainland China: Medical services, management consulting, and software R&D. 10. Impact on financial operations: None. 11. Investment amount and shareholding ratio: None. 12. Other matters: None.